Skip to content

Latest News

Molecular Products Group, an Arlington Capital Partners portfolio company, announces acquisition of the O.C. Lugo Company

4th NOVEMBER 2019

Molecular Products Group, (“Molecular Products” or the “Company”), a portfolio company of Arlington Capital Partners (“Arlington Capital”), today announced the acquisition of the O.C. Lugo Company.

The O.C. Lugo Company, located in Connellsville, PA, manufactures sodium chlorate-based chemical oxygen generators, and is a prime contractor for the United States Navy. Chemical oxygen generators are devices used to produce pure, breathable oxygen for use in enclosed spaces, including submarines.
Troy Rhudy, CEO of the Molecular Products Group, said, “As the world leader in chemical oxygen generation systems, Molecular Products is excited to welcome the O.C. Lugo Company into the Group. Our combined capabilities will support our continued growth in the defense industry while strengthening our service to our global customer base.”
“The acquisition of the O.C. Lugo Company demonstrates Molecular Products’ continued investment in its market-leading chemical oxygen generation franchise. The transaction expands the Company’s product offerings and provides another key chemical oxygen generator manufacturing site in addition to our existing capacity in Harlow, England and in our state-of-the-art Louisville, CO facility,” said Peter Manos, a Managing Partner at Arlington Capital Partners.
Malcolm Little, a Partner at Arlington Capital, added, “This is Molecular Products’ second strategic acquisition in the last twelve months. We are very excited for the tremendous growth opportunities these highly complementary acquisitions bring in each of Molecular Products’ core markets.”